Back to the directory
TYBR Health
Natural hydrogel to keep internal organs scar-free after surgery
- Founded
- 2020
- Status
- Active
- Stage
- Early
- Team size
- 3
- Location
- Houston, TX, USA
- Category
- Biotech & Drug Discovery
- Sector
- Medical Devices
About TYBR Health
TYBR is developing a hydrogel to limit internal scarring after surgery. The naturally derived material is applied to coat tendons at the end of surgery to improve healing outcomes for the millions Americans who undergo tendon or ligament surgery each year.
B2BMedical Devices
FDA clearances
1 510(k) clearance on record, 2025.
- TYBR Collagen Gel
K250109
Source: FDA 510(k) database via openFDA.
Securities filings
4 Form D filings on record, 2020 to 2026.
Filed as TYBR Health, Inc.
Source: SEC EDGAR. Form D reports an exempt offering; it does not confirm funds raised.
Company data compiled and maintained by Healthcare Discovery.
